The EACPT has just released a library of
almost 60 videos of talks from the 2015 Madrid
|
Plaza Major, Madrid |
Congress. These
videos are now available for EACPT members within the members’ pages of
the EACPT website. See below for the list of
speakers and their topics, ranging from Alzheimer's to cancer, treating
children, regulating medicines, the patient's voice, medicines for low resource
global settings, biosimilars, and patient safety.
Access to the videos is free for Individual
Associate members of the EACPT.
To view the videos as an existing EACPT
member, open the ‘Publications’ drop down menu on the members' pages of the
website.
Anyone from anywhere in the world with a
professional interest in clinical pharmacology and/or therapeutics can now join
the EACPT as an Individual Associate member.
Membership benefits include:
- Access
to videos of talks from EACPT Meetings
- Discounted
registration fees for EACPT meetings
- Online
access to the Official EACPT Journal - Clinical Therapeutics
- Access
to the EACPT’s worldwide network of Individual Associate Members
- Active
involvement in EACPT
If you are an existing Individual Associate
member of the EACPT and have any query regarding your membership login details
for the website, please contact eacptmembership@kenes.com.
This new portfolio of videos enriches the
existing library of videos of talks available on the EACPT
members’ website from the EACPT Cardiovascular focus meeting held in
Nijmegen in 2014.
Main topics and speakers
Biosimilar medicinal products. How to enhance
healthcare systems sustainability without compromising clinical practice.
Martina Weise (Germany), Cristina Avendaño-Solá (Spain), Aleksandra Grozdanova
(Macedonia)
Debate on therapeutic innovation: Does
industry research meet the needs of society?
Xavier Carné (Spain) vs. Ruth Diazaraque (United Kingdom)
Debate on pharmacoepidemiology databases
Miriam CJM Sturkenboom (The Netherlands) vs. Tom MacDonald (United Kingdom)
Current challenges in cancer treatment.
Luis Paz Ares (Spain)
Novel insights in ADME
Janne Backman (Finland), Amin Rostami (United Kingdom)
Handling medicines in special populations
- Renal function in older people: Emmanuelle
Vidal-Petiot (France)
- Rational pharmacotherapy in children: Imti
Choonara (United Kingdom)
- Appropriate prescribing in older patients:
Beatriz Montero (Spain)
Medicines and Global Health
Nicola Magrini (WHO, Switzerland), Lembit Rägo (WHO, Switzerland). Raj Long
(Bill and Melinda Gates Foundation, UK), Antoni Plasencia (Spain)
Drug development for regulatory approval and
reimbursement decisions
Beate Wieseler (Germany), Pierre Demolis (France), Bruno Flamion (Belgium)
Key factors for successful research in Europe
Rafael de Andrés Medina (Spain), Jacques Demotes (France), Javier Urzay (Spain)
Implementation of Pharmacogenetics and
Personalised Medicine in Clinical Practice
Raul A. Kiivet (Estonia)
Interventions that improve the use of
medicines in clinical practice
Tormod K Bjånes (Norway), Romaldas Maciulaitis (Lithuania), Milan Grundmann
(Czech Republic), Espen Jimenez-Solem (Denmark), Carl-Olav Stiller (Sweden),
Mikkel Christensen (Denmark), Cornelis Kramers (Netherlands), Kirstine Moll
Harboe (Denmark), Cándido Hernández-López (Spain)
Biomarkers in Alzheimer clinical research
Claudio Babiloni (Italy)
Medicines regulation, access to medicines and
the patient’s voice
Denis Pouchain (France), Nick Meade (United Kingdom), Toni Gilabert (Spain)
Heterogeneity in drug response
Juan Tamargo (Spain), Caridad Pontes (Spain), Eduard Vieta (Spain)
Immunopharmacology of TNF-alpha:
disease-transcending therapies
Roman Fischer (Germany), Johannan Brandse (The Netherlands), Marie-Christophe
Boissier (France)
Pharmacovigilance - Risk communication to
health professionals and citizens
Barbara Rath (Germany), Almath Spooner (Ireland), Frederic Bouder (Netherlands)
Drug Information and Decision Support Systems
to support rational drug treatment
Robert Vander Stichele (Belgium), Ylva Böttiger (Sweden)
Hepatitis B reactivation. How to manage the
risk?
José Luis Calleja (Spain)
Progressive multifocal leukoencephalopathy.
Risk perception in the therapeutic context
Brigitte Keller-Stanislawski (Germany)
Registries for long-term risks
Ignacio García Doval (Spain)
Drug Induced Liver Injury
Raúl Andrade (Spain), Paul Watkins (USA), Michael Merz (Switzerland), Herve Le
Louët (France)
Training on medicines regulation
Arantxa Sancho, Martina Weise, Jorge Camarero, Antonio Gomez-Oute